Literature DB >> 30470656

The virtual reality of Parkinson's disease freezing of gait: A systematic review.

Brent Bluett1, Ece Bayram2, Irene Litvan3.   

Abstract

INTRODUCTION: Freezing of gait is an episodic inability to move the feet forward despite the intention to walk. It is a common cause of falls and subsequent morbidity and mortality in Parkinson's disease. Virtual reality paradigms provide an opportunity to safely evaluate freezing of gait, in order to better understand the underlying pathophysiology. This article focuses on the methodology, threshold used to define freezing of gait, results, limitations of studies using virtual reality paradigms, and proposes future directions of research. Summarizing these articles improves our understanding of freezing of gait in Parkinson's disease, and critical evaluation provides an opportunity for future studies to improve upon these efforts.
METHODS: We performed a systematic review following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement guidelines, of studies using VR paradigms to elucidate the underlying pathophysiology of PD-FOG.
RESULTS: This review initially identified 57 articles, but after exclusion of duplicates, abstracts, and studies not focused on the underlying pathophysiology of this disorder, 12 peer-reviewed articles using virtual reality paradigms to evaluate freezing of gait in Parkinson's disease were found.
CONCLUSION: Virtual reality paradigms are able to reproduce freezing of gait. Studies using MRI compatible virtual reality to evaluate freezing of gait found dysfunctional connectivity between cortical and subcortical structures during episodes. However, several important limitations of these studies should caution our interpretation of these results. Future studies which improve the design and methodology are needed to ultimately identify the cause and subsequent treatments for freezing of gait in Parkinson's disease.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Freezing of gait; Parkinson's disease; Virtual reality

Mesh:

Year:  2018        PMID: 30470656      PMCID: PMC6773254          DOI: 10.1016/j.parkreldis.2018.11.013

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  29 in total

1.  Pattern of brain tissue loss associated with freezing of gait in Parkinson disease.

Authors:  V S Kostic; F Agosta; M Pievani; E Stefanova; M Jecmenica-Lukic; A Scarale; V Spica; M Filippi
Journal:  Neurology       Date:  2012-01-25       Impact factor: 9.910

2.  Using virtual reality to explore the role of conflict resolution and environmental salience in freezing of gait in Parkinson's disease.

Authors:  Elie Matar; James M Shine; Sharon L Naismith; Simon J G Lewis
Journal:  Parkinsonism Relat Disord       Date:  2013-07-04       Impact factor: 4.891

3.  Modeling freezing of gait in Parkinson's disease with a virtual reality paradigm.

Authors:  J M Shine; E Matar; S J Bolitho; V Dilda; T R Morris; S L Naismith; S T Moore; S J G Lewis
Journal:  Gait Posture       Date:  2012-12-04       Impact factor: 2.840

4.  Assessing the utility of Freezing of Gait Questionnaires in Parkinson's Disease.

Authors:  J M Shine; S T Moore; S J Bolitho; T R Morris; V Dilda; S L Naismith; S J G Lewis
Journal:  Parkinsonism Relat Disord       Date:  2011-08-26       Impact factor: 4.891

5.  Longitudinal fMRI analysis: A review of methods.

Authors:  Martha Skup
Journal:  Stat Interface       Date:  2010       Impact factor: 0.582

6.  Reliability of measurements obtained with the Timed "Up & Go" test in people with Parkinson disease.

Authors:  S Morris; M E Morris; R Iansek
Journal:  Phys Ther       Date:  2001-02

7.  Using the Timed Up & Go test in a clinical setting to predict falling in Parkinson's disease.

Authors:  Joe R Nocera; Elizabeth L Stegemöller; Irene A Malaty; Michael S Okun; Michael Marsiske; Chris J Hass
Journal:  Arch Phys Med Rehabil       Date:  2013-03-06       Impact factor: 3.966

8.  Virtual reality walking and dopamine: opening new doorways to understanding freezing of gait in Parkinson's disease.

Authors:  E Matar; J M Shine; S L Naismith; S J G Lewis
Journal:  J Neurol Sci       Date:  2014-07-01       Impact factor: 3.181

9.  Freezing of gait in Parkinson's disease is associated with functional decoupling between the cognitive control network and the basal ganglia.

Authors:  James M Shine; Elie Matar; Philip B Ward; Michael J Frank; Ahmed A Moustafa; Mark Pearson; Sharon L Naismith; Simon J G Lewis
Journal:  Brain       Date:  2013-10-18       Impact factor: 13.501

10.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  PLoS Med       Date:  2009-07-21       Impact factor: 11.069

View more
  4 in total

1.  Stereotactic Surgery of Parkinson's Disease with Magnetic Resonance Imaging under Three-Dimensional Mark Point Positioning Algorithm.

Authors:  Yuan Jia; Zengguang Wang; Xiang Sun; Yipin Zhou
Journal:  Contrast Media Mol Imaging       Date:  2022-06-26       Impact factor: 3.009

Review 2.  Virtual reality in research and rehabilitation of gait and balance in Parkinson disease.

Authors:  Colleen G Canning; Natalie E Allen; Evelien Nackaerts; Serene S Paul; Alice Nieuwboer; Moran Gilat
Journal:  Nat Rev Neurol       Date:  2020-06-26       Impact factor: 42.937

Review 3.  Recent Trends and Practices Toward Assessment and Rehabilitation of Neurodegenerative Disorders: Insights From Human Gait.

Authors:  Ratan Das; Sudip Paul; Gajendra Kumar Mourya; Neelesh Kumar; Masaraf Hussain
Journal:  Front Neurosci       Date:  2022-04-15       Impact factor: 5.152

Review 4.  The Challenges and Perspectives of the Integration Between Virtual and Augmented Reality and Manual Therapies.

Authors:  Francesco Cerritelli; Marco Chiera; Marco Abbro; Valentino Megale; Jorge Esteves; Alberto Gallace; Andrea Manzotti
Journal:  Front Neurol       Date:  2021-06-30       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.